A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations

Clinical Trial Grant

Duke Scholars

Principal Investigator Laura Ruth Alder Medicine, Medical Oncology

Awarded By

Iambic Therapeutics, Inc.

Start Date

August 28, 2025

End Date

August 24, 2030

Awarded By

Iambic Therapeutics, Inc.

Start Date

August 28, 2025

End Date

August 24, 2030